These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33074358)

  • 1. The impact of timing and modalities of dental prophylaxis on the risk of 5-fluorouracil-related oral mucositis in patients with head and neck cancer: a nationwide population-based cohort study.
    Huang YF; Liu SP; Muo CH; Chen HJ; Liao YF; Chiu KM; Chen CC; Tsai CH; Hong HH; Chang CT
    Support Care Cancer; 2021 Jun; 29(6):3163-3171. PubMed ID: 33074358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dental Prophylaxis and Osteoradionecrosis: A Population-Based Study.
    Chang CT; Liu SP; Muo CH; Tsai CH; Huang YF
    J Dent Res; 2017 May; 96(5):531-538. PubMed ID: 28095728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies.
    Sorensen JB; Skovsgaard T; Bork E; Damstrup L; Ingeberg S
    Cancer; 2008 Apr; 112(7):1600-6. PubMed ID: 18300265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of oral mucositis due to 5-fluorouracil treatment with oral cryotherapy.
    Baydar M; Dikilitas M; Sevinc A; Aydogdu I
    J Natl Med Assoc; 2005 Aug; 97(8):1161-4. PubMed ID: 16173332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer.
    Chung YL; Pui NNM
    Support Care Cancer; 2017 Sep; 25(9):2743-2751. PubMed ID: 28353040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
    Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T
    Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
    Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between dental therapy timelines and osteoradionecrosis: a nationwide population-based cohort study.
    Huang YF; Liu SP; Muo CH; Tsai CH; Chang CT
    Clin Oral Investig; 2020 Jan; 24(1):455-463. PubMed ID: 31111283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Mouse Model for Oral Mucositis Induced by Cancer Chemotherapy.
    Shimamura Y; Takeuchi I; Terada H; Makino K
    Anticancer Res; 2018 Jan; 38(1):307-312. PubMed ID: 29277788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma.
    Vera-Llonch M; Oster G; Hagiwara M; Sonis S
    Cancer; 2006 Jan; 106(2):329-36. PubMed ID: 16342066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between TNF-α gene promoter polymorphism (- 1211 T > C), the plasma concentration of TNF-α, and risk of oral mucositis and shortening of overall survival in patients subjected to intensity-modulated radiation therapy due to head and neck cancer.
    Mlak R; Powrózek T; Brzozowska A; Homa-Mlak I; Mazurek M; Gołębiowski P; Sobieszek G; Małecka-Massalska T
    Support Care Cancer; 2020 Feb; 28(2):531-540. PubMed ID: 31076897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of oral submucous fibrosis on chemotherapy-induced mucositis for head and neck cancer in a geographic area in which betel quid chewing is prevalent.
    Wang HM; Wang CH; Chen JS; Su CL; Liao CT; Chen IH
    Am J Clin Oncol; 1999 Oct; 22(5):485-8. PubMed ID: 10521064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
    Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
    Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, biochemical and histological study of the effect of antimicrobial photodynamic therapy on oral mucositis induced by 5-fluorouracil in hamsters.
    Cruz Éde P; Campos L; Pereira Fda S; Magliano GC; Benites BM; Arana-Chavez VE; Ballester RY; Simões A
    Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):298-309. PubMed ID: 25612464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].
    Nagatani A; Ogawa Y; Sunaga T; Tomura K; Naito Y; Fujii N; Okabe T; Hashimoto T; Kogo M; Sasaki T
    Yakugaku Zasshi; 2017; 137(2):221-225. PubMed ID: 28154335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary alpha-1-antitrypsin and macrophage migration inhibitory factor may be potential prognostic biomarkers for oncologic treatment-induced severe oral mucositis.
    Palmier NR; Leme AFP; De Rossi T; Telles GP; Morais-Faria K; Kowalski LP; Marta GN; Brandão TB; Arany PR; Migliorati CA; Santos-Silva AR; Prado-Ribeiro AC
    Support Care Cancer; 2021 Jun; 29(6):2939-2946. PubMed ID: 33009579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
    Elting LS; Cooksley CD; Chambers MS; Garden AS
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1110-20. PubMed ID: 17398022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer.
    Humerickhouse RA; Dolan ME; Haraf DJ; Brockstein B; Stenson K; Kies M; Sulzen L; Ratain MJ; Vokes EE
    Clin Cancer Res; 1999 Feb; 5(2):291-8. PubMed ID: 10037177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism of Promoter Region of TNFRSF1A Gene (-610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients.
    Brzozowska A; Powrózek T; Homa-Mlak I; Mlak R; Ciesielka M; Gołębiowski P; Małecka-Massalska T
    Pathol Oncol Res; 2018 Jan; 24(1):135-143. PubMed ID: 28401452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association with xerostomia from sialadenitis and the jaw osteonecrosis in head and neck cancer population: a nationwide cohort study.
    Huang YF; Muo CH; Tsai CH; Liu SP; Chang CT
    Clin Oral Investig; 2019 Feb; 23(2):585-593. PubMed ID: 29725850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.